Delivery Order SPE2DB20D2104-SPE2DB25FNATN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,915.46 under a firm fixed price contract. This delivery order, which is expected to be completed by September 5, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,975.64 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,739.26 on September 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 18, 2025, with performance originating from the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,691.69. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement, consistent with the company's standard federal contracting...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $17,160.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections in 0.5 ml doses, valued at $10,714.36. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with a ceiling value of $4,883.67. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,619.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made without...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNATNDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,060.08 delivery order on September 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5ml) with an ultimate completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical transaction within AmerisourceBergen's broader federal procurement portfolio supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, medical supplies, and specialty pharmaceuticals to support Defense Health Agency and other government healthcare programs worldwide. Trulicity, a diabetes management medication, exemplifies the company's role as a critical vendor for brand-name pharmaceutical products within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/17/25 |